Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-9-6
pubmed:abstractText
We studied the distribution of 5-hydroxytryptamine- (5-HT-) containing cells in the guinea pig pancreas and examined the effects of 5-HT on fluid secretion by interlobular pancreatic ducts. The 5-HT-immunoreactive cells with morphological characteristics of enterochromaffin (EC) cells were scattered throughout the duct system and were enriched in islets of Langerhans. The fluid secretory rate in the isolated interlobular ducts was measured by videomicroscopy. Basolateral applications of 5-HT strongly but reversibly reduced HCO(3)-dependent, as well as secretin- and acetylcholine- (ACh-) stimulated, fluid secretion, whereas 5-HT applied into the lumen had no such effects. Secretin-stimulated fluid secretion could be inhibited by a 5-HT(3) receptor agonist, but not by agonists of the 5-HT(1), 5-HT(2), or 5-HT(4) receptors. Under the stimulation with secretin, 5-HT decreased the intracellular pH (pH(i)) and reduced the rate of pH(i) recovery after acid loading with NH(4)(+), suggesting that 5-HT inhibits the intracellular accumulation of HCO3(-). The elevation of intraductal pressure in vivo reduced secretin-stimulated fluid secretion, an effect that could be attenuated by a 5-HT(3) receptor antagonist. Thus, 5-HT, acting through basolateral 5-HT(3) receptors, strongly inhibits spontaneous, secretin-, and ACh-stimulated fluid secretion by guinea pig pancreatic ducts. 5-HT released from pancreatic ductal EC cells on elevation of the intraductal pressure may regulate fluid secretion of neighboring duct cells in a paracrine fashion.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-10409150, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-10457070, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-10457081, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-10658921, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-10833495, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-1348566, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-13655213, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-1434099, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-1698981, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-1699602, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-1718042, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-1940027, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-1951703, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-2159059, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-2472553, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-3552241, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-359742, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-4943990, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-6194039, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-6357137, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-7532365, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-8223911, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-8866360, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-8866361, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-9021650, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-9706019, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-9756515, http://linkedlifedata.com/resource/pubmed/commentcorrection/11544281-9758234
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
108
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
749-56
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:11544281-Acetylcholine, pubmed-meshheading:11544281-Animals, pubmed-meshheading:11544281-Bicarbonates, pubmed-meshheading:11544281-Calcium, pubmed-meshheading:11544281-Culture Techniques, pubmed-meshheading:11544281-Female, pubmed-meshheading:11544281-Guinea Pigs, pubmed-meshheading:11544281-Hydrogen-Ion Concentration, pubmed-meshheading:11544281-Immunohistochemistry, pubmed-meshheading:11544281-Models, Biological, pubmed-meshheading:11544281-Pancreas, pubmed-meshheading:11544281-Pancreatic Ducts, pubmed-meshheading:11544281-Pancreatic Juice, pubmed-meshheading:11544281-Pressure, pubmed-meshheading:11544281-Receptors, Serotonin, pubmed-meshheading:11544281-Receptors, Serotonin, 5-HT3, pubmed-meshheading:11544281-Secretin, pubmed-meshheading:11544281-Serotonin, pubmed-meshheading:11544281-Serotonin Receptor Agonists
pubmed:year
2001
pubmed:articleTitle
5-hydroxytryptamine strongly inhibits fluid secretion in guinea pig pancreatic duct cells.
pubmed:affiliation
Internal Medicine II, Nagoya University School of Medicine, Nagoya, Japan.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't